about
Unraveling the Effect of Immunogenicity on the PK/PD, Efficacy, and Safety of Therapeutic ProteinsOzanezumab dose selection for amyotrophic lateral sclerosis by pharmacokinetic-pharmacodynamic modelling of immunohistochemistry data from patient muscle biopsiesCombined Analysis of Phase I and Phase II Data to Enhance the Power of Pharmacogenetic Tests.Update on the Genetic Polymorphisms of Drug-Metabolizing Enzymes in Antiepileptic Drug Therapy.A novel Gibbs maximum a posteriori (GMAP) approach on Bayesian nonlinear mixed-effects population pharmacokinetics (PK) modelsPharmacokinetics of ciprofloxacin in the human eye: a clinical study and population pharmacokinetic analysis.Using physiologically-based pharmacokinetic-guided "body-on-a-chip" systems to predict mammalian response to drug and chemical exposureClinical pharmacology = disease progression + drug actionPharmacokinetics of recombinant activated factor VII in trauma patients with severe bleedingExpanding clinical applications of population pharmacodynamic modelling.Paroxetine: population pharmacokinetic analysis in late-life depression using sparse concentration sampling.Population pharmacokinetics of gemcitabine and its metabolite in patients with cancer: effect of oxaliplatin and infusion ratePopulation pharmacokinetics of chloroquine and sulfadoxine and treatment response in children with malaria: suggestions for an improved dose regimenOral treatment with etoposide in small cell lung cancer - dilemmas and solutions.Atomoxetine: A Review of Its Pharmacokinetics and Pharmacogenomics Relative to Drug Disposition.Population pharmacokinetic analysis for risperidone using highly sparse sampling measurements from the CATIE studyMontelukast in the treatment of perennial allergic rhinitis in paediatric Japanese patients; an open-label clinical trial.Unexpectedly high affinity of a novel histamine H(3) receptor antagonist, GSK239512, in vivo in human brain, determined using PET.Effect of rifampicin and efavirenz on moxifloxacin concentrations when co-administered in patients with drug-susceptible TB.Evaluation of the Population Pharmacokinetic Properties of Lidocaine and its Metabolites After Long-Term Multiple Applications of a Lidocaine Plaster in Post-Herpetic Neuralgia Patients.Comparison of Nonlinear Mixed Effects Models and Noncompartmental Approaches in Detecting Pharmacogenetic Covariates.Pharmacokinetic/pharmacodynamic integration in drug development and dosage-regimen optimization for veterinary medicine.Physiologically based pharmacokinetic modelling: a sound mechanistic basis is needed.Pharmacokinetic Considerations for Combining Antiretroviral Therapy, Direct-Acting Antiviral Agents for Hepatitis C Virus, and Addiction Treatment Medications.Living inside the box: environmental effects on mouse models of human disease
P2860
Q28066498-E51ED444-66D6-4008-8B18-E0F78B562D6AQ28543591-53AFDC07-1591-4EA3-9279-2A52D4E26312Q31074808-9FEFA929-E763-4585-8934-D12BF2BB6771Q33664128-30283C40-6877-46A1-9E2B-EB37E63C3263Q33692989-728F4B53-55EE-41CC-BCEB-C6EBA1251108Q33979807-7DF9703D-EB28-4F79-9E4C-8D504B6452D3Q34143269-25E49FFA-60EF-4EA4-8440-1D14CA0DE31AQ34953659-FA53E762-4763-45E1-9A70-79D2C48A045BQ35544621-9D39B6EE-3E3A-483E-AA72-3D42A76B6D41Q35803310-554AECF6-083C-4135-899F-60A8A97F69ACQ35827538-01029B5B-3CAF-4834-83FE-7B2313D55923Q36535928-AF110786-C0CF-44F2-A100-62B131DA6EAEQ36536401-45B5105A-77A4-4B31-A8A3-D47D9671AEB7Q36613874-D56581E9-1215-47B4-AC03-6BA82DF7E14DQ36925745-2E226DBE-2A24-4BDF-861F-358510C89FCDQ37142429-87006D50-BBA9-4A54-AE5C-383FA222C09AQ37291969-6C7D612D-3399-4036-8BBB-8F08AF74CE2FQ37635268-1C1064BA-1D6F-48F1-9FCD-371BEB490290Q38973113-E2D172D9-554B-44B7-A9E1-766F9A7E587BQ39025692-6F43E8DA-C1F3-4672-AFA6-62C96C65E074Q39885479-DF5B2B89-E892-4095-BAD8-AC6276A728D3Q42104275-E7418137-F52E-409E-8C92-92115BDFA759Q42758802-BB7A262B-82DD-4350-B781-3E777B939EBCQ45330127-638FFF66-E524-416A-A09A-9E29E998F8F8Q58790199-1703DCD4-DDD6-4CDA-A576-F0E558A0FB78
P2860
description
1991 nî lūn-bûn
@nan
1991 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Population pharmacokinetics: theory and practice.
@ast
Population pharmacokinetics: theory and practice.
@en
Population pharmacokinetics: theory and practice.
@nl
type
label
Population pharmacokinetics: theory and practice.
@ast
Population pharmacokinetics: theory and practice.
@en
Population pharmacokinetics: theory and practice.
@nl
prefLabel
Population pharmacokinetics: theory and practice.
@ast
Population pharmacokinetics: theory and practice.
@en
Population pharmacokinetics: theory and practice.
@nl
P2860
P1476
Population pharmacokinetics: theory and practice.
@en
P2093
P2860
P304
P407
P577
1991-12-01T00:00:00Z